These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1412 related items for PubMed ID: 23197178

  • 1. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D, Athimang W, Paisooksantivatana K, Mongkolsuk T, Ingsathit A, Worawichawong S, Kitpoka P, Jirasiritham S, Kantachuvesiri S.
    Transplant Proc; 2012 Jan 27; 44(1):62-5. PubMed ID: 22310580
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 27; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 8. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
    Hirai T, Kohei N, Omoto K, Ishida H, Tanabe K.
    Transpl Int; 2012 Sep 27; 25(9):925-34. PubMed ID: 22764746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar 27; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 11. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.
    Transplant Proc; 2012 Nov 27; 44(9):2529-31. PubMed ID: 23146444
    [Abstract] [Full Text] [Related]

  • 12. Understanding the significance of low-level preformed donor-specific anti-HLA antibodies in renal transplant patients.
    Wu P, Everly MJ, Jin J, Mao Y, Chen J.
    Clin Transpl; 2011 Nov 27; ():365-8. PubMed ID: 22755432
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M, Bartel G, Exner M, Regele H, Körmöczi GF, Fischer GF, Böhmig GA.
    Transpl Int; 2009 Oct 27; 22(10):982-9. PubMed ID: 19619171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.
    Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S.
    Clin Transplant; 2012 Oct 27; 26(4):644-56. PubMed ID: 22432638
    [Abstract] [Full Text] [Related]

  • 19. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC.
    Transplant Proc; 2011 Dec 27; 43(10):3840-6. PubMed ID: 22172857
    [Abstract] [Full Text] [Related]

  • 20. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.
    Transplant Proc; 2007 Nov 27; 39(9):2718-20. PubMed ID: 18021967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.